All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ1755 | Anti-PACSIN3 (CBXS-4026) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4026 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5179 | Anti-PACSIN3 (CBXS-4026) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4026 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0235-YC | Anti-PACSIN3 (2A3) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2A3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0236-YC | Anti-PACSIN3 (2A6) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2A6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0237-YC | Anti-PACSIN3 (2D7) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 2D7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0238-YC | Anti-PACSIN3 (4F8) h(scFv-41BB-CD3ζ) CAR, pCDCAR1 | Human | 4F8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0646-YC | Anti-PACSIN3 (2A3) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2A3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0647-YC | Anti-PACSIN3 (2A6) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2A6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0648-YC | Anti-PACSIN3 (2D7) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 2D7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-M0649-YC | Anti-PACSIN3 (4F8) h(scFv-CD28-CD3ζ) CAR, pCDCAR1 | Human | 4F8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION